What is AnswersNow?
AnswersNow operates at the intersection of health-tech and behavioral science, providing a sophisticated virtual platform that connects families with highly trained Board Certified Behavior Analysts (BCBAs). The company's core value proposition lies in its AI-driven learning modules, which tailor therapy to the unique interests of each child, thereby increasing engagement and clinical efficacy. By integrating with both commercial insurers and Medicaid, the firm has effectively lowered the barrier to entry for high-quality care. This market-leading approach not only optimizes therapy hours but also provides a sustainable, cost-effective solution for payors, positioning AnswersNow as a transformative force in the pediatric behavioral health landscape.
How much funding has AnswersNow raised?
AnswersNow has raised a total of $51.1M across 3 funding rounds:
Debt
$76K
Series A
$11M
Series B
$40M
Debt (2021): $76K with participation from PPP
Series A (2023): $11M led by Difference Partners, Blue Heron Capital, Left Lane Capital, and American Family Institute for Social Impact
Series B (2026): $40M supported by Left Lane Capital, Owl Ventures, and HealthQuest Capital
Key Investors in AnswersNow
Left Lane Capital
A New York-based growth equity firm that invests in high-growth consumer internet and technology companies, focusing on businesses that build lasting relationships with their customers.
Owl Ventures
A global leader in edtech investing, specializing in innovative solutions that enhance learning experiences and democratize access to quality education.
HealthQuest Capital
A growth capital firm dedicated to transforming healthcare through innovations in medical devices, technologies, and services, with a focus on improving patient outcomes.
What's next for AnswersNow?
With this latest injection of growth capital, AnswersNow is poised to scale its operations significantly, focusing on expanding its provider network and enhancing its AI-driven diagnostic capabilities. The strategic roadmap includes deepening its integration with major healthcare payors to ensure broader coverage across additional states. As the company transitions into a more mature phase of its lifecycle, the focus will shift toward long-term clinical outcome validation and the potential for broader application of its behavioral health technology. Investors are closely watching how the firm leverages this backing to solidify its position as a category-defining leader in the digital autism therapy market.
See full AnswersNow company page
